Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling.
Stadler S, Nguyen CH, Schachner H, Milovanovic D, Holzner S, Brenner S, Eichsteininger J, Stadler M, Senfter D, Krenn L, Schmidt WM, Huttary N, Krieger S, Koperek O, Bago-Horvath Z, Brendel KA, Marian B, de Wever O, Mader RM, Giessrigl B, Jäger W, Dolznig H, Krupitza G. Stadler S, et al. Among authors: krupitza g. Cell Mol Life Sci. 2017 May;74(10):1907-1921. doi: 10.1007/s00018-016-2441-5. Epub 2016 Dec 24. Cell Mol Life Sci. 2017. PMID: 28013338 Free PMC article.
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Saiko P, Bauer W, Horvath Z, Hoechtl T, Grusch M, Illmer C, Madlener S, Krupitza G, Mader RM, Schott H, Fritzer-Szekeres M, Szekeres T. Saiko P, et al. Among authors: krupitza g. Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1507-11. doi: 10.1081/NCN-200027723. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571287
Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.
Saiko P, Horvath Z, Illmer C, Madlener S, Bauer W, Hoechtl T, Erlach N, Grusch M, Krupitza G, Mader RM, Jaeger W, Schott H, Agarwal RP, Fritzer-Szekeres M, Szekeres T. Saiko P, et al. Among authors: krupitza g. Leuk Res. 2005 Jul;29(7):785-91. doi: 10.1016/j.leukres.2004.12.015. Epub 2005 Feb 19. Leuk Res. 2005. PMID: 15927674
Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
Maier S, Strasser S, Saiko P, Leisser C, Sasgary S, Grusch M, Madlener S, Bader Y, Hartmann J, Schott H, Mader RM, Szekeres T, Fritzer-Szekeres M, Krupitza G. Maier S, et al. Among authors: krupitza g. Apoptosis. 2006 Mar;11(3):427-40. doi: 10.1007/s10495-006-4066-x. Apoptosis. 2006. PMID: 16538382
5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
Strasser S, Maier S, Leisser C, Saiko P, Madlener S, Bader Y, Bernhaus A, Gueorguieva M, Richter S, Mader RM, Wesierska-Gadek J, Schott H, Szekeres T, Fritzer-Szekeres M, Krupitza G. Strasser S, et al. Among authors: krupitza g. Differentiation. 2006 Dec;74(9-10):488-98. doi: 10.1111/j.1432-0436.2006.00082.x. Differentiation. 2006. PMID: 17177846
Molecular mechanisms of drug resistance.
Mader RM, Schmidt WM, Steger GG, Krupitza G. Mader RM, et al. Among authors: krupitza g. Int J Clin Pharmacol Ther. 2009 Jan;47(1):49-50. doi: 10.5414/cpp47049. Int J Clin Pharmacol Ther. 2009. PMID: 19203537 No abstract available.
Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells.
Vo NT, Madlener S, Bago-Horvath Z, Herbacek I, Stark N, Gridling M, Probst P, Giessrigl B, Bauer S, Vonach C, Saiko P, Grusch M, Szekeres T, Fritzer-Szekeres M, Jäger W, Krupitza G, Soleiman A. Vo NT, et al. Among authors: krupitza g. Carcinogenesis. 2010 Dec;31(12):2074-81. doi: 10.1093/carcin/bgp199. Epub 2009 Aug 20. Carcinogenesis. 2010. PMID: 19696164
A polar extract of the Maya healing plant Anthurium schlechtendalii (Aracea) exhibits strong in vitro anticancer activity.
Stark N, Gridling M, Madlener S, Bauer S, Lackner A, Popescu R, Diaz R, Tut FM, Vo TP, Vonach C, Giessrigl B, Saiko P, Grusch M, Fritzer-Szekeres M, Szekeres T, Kopp B, Frisch R, Krupitza G. Stark N, et al. Among authors: krupitza g. Int J Mol Med. 2009 Oct;24(4):513-21. doi: 10.3892/ijmm_00000260. Int J Mol Med. 2009. PMID: 19724892
140 results